Secondary preventive medication persistence and adherence 1 year after stroke
- PMID: 21900638
- PMCID: PMC3265047
- DOI: 10.1212/WNL.0b013e31822f0423
Secondary preventive medication persistence and adherence 1 year after stroke
Abstract
Objective: Data on long-term use of secondary prevention medications following stroke are limited. The Adherence eValuation After Ischemic stroke-Longitudinal (AVAIL) Registry assessed patient, provider, and system-level factors influencing continuation of prevention medications for 1 year following stroke hospitalization discharge.
Methods: Patients with ischemic stroke or TIA discharged from 106 hospitals participating in the American Heart Association Get With The Guidelines-Stroke program were surveyed to determine their use of warfarin, antiplatelet, antihypertensive, lipid-lowering, and diabetes medications from discharge to 12 months. Reasons for stopping medications were ascertained. Persistence was defined as continuation of all secondary preventive medications prescribed at hospital discharge, and adherence as continuation of prescribed medications except those stopped according to health care provider instructions.
Results: Of the 2,880 patients enrolled in AVAIL, 88.4% (2,457 patients) completed 1-year interviews. Of these, 65.9% were regimen persistent and 86.6% were regimen adherent. Independent predictors of 1-year medication persistence included fewer medications prescribed at discharge, having an adequate income, having an appointment with a primary care provider, and greater understanding of why medications were prescribed and their side effects. Independent predictors of adherence were similar to those for persistence.
Conclusions: Although up to one-third of stroke patients discontinued one or more secondary prevention medications within 1 year of hospital discharge, self-discontinuation of these medications is uncommon. Several potentially modifiable patient, provider, and system-level factors associated with persistence and adherence may be targets for future interventions.
Figures
Similar articles
-
Persistence of secondary prevention medication and related factors for acute ischemic stroke and transient ischemic attack in China.Neurol Res. 2017 Jun;39(6):492-497. doi: 10.1080/01616412.2017.1312792. Epub 2017 Apr 19. Neurol Res. 2017. PMID: 28420316
-
Persistence with stroke prevention medications 3 months after hospitalization.Arch Neurol. 2010 Dec;67(12):1456-63. doi: 10.1001/archneurol.2010.190. Epub 2010 Aug 9. Arch Neurol. 2010. PMID: 20697032 Free PMC article.
-
Persistence of secondary prevention medications after acute ischemic stroke or transient ischemic attack in Chinese population: data from China National Stroke Registry.Neurol Res. 2013 Jan;35(1):29-36. doi: 10.1179/1743132812Y.0000000107. Neurol Res. 2013. PMID: 23317796
-
Multimodal Interventions to Enhance Adherence to Secondary Preventive Medication after Stroke: A Systematic Review and Meta-Analyses.Cardiovasc Ther. 2016 Apr;34(2):85-93. doi: 10.1111/1755-5922.12176. Cardiovasc Ther. 2016. PMID: 26820710 Review.
-
Post-stroke medication adherence and persistence rates: a meta-analysis of observational studies.J Neurol. 2021 Jun;268(6):2090-2098. doi: 10.1007/s00415-019-09660-y. Epub 2019 Dec 2. J Neurol. 2021. PMID: 31792672 Review.
Cited by
-
Investigation of vascular risk factor control and secondary prevention medication compliance in acute ischemic stroke.Front Neurol. 2024 Jun 21;15:1365860. doi: 10.3389/fneur.2024.1365860. eCollection 2024. Front Neurol. 2024. PMID: 38974682 Free PMC article.
-
Trends in the Use of Medications for Secondary Ischemic Stroke Prevention in Denmark, 2005-2021.Neurology. 2024 May 14;102(9):e209309. doi: 10.1212/WNL.0000000000209309. Epub 2024 Apr 22. Neurology. 2024. PMID: 38648572
-
The machine learning methods to analyze the using strategy of antiplatelet drugs in ischaemic stroke patients with gastrointestinal haemorrhage.BMC Neurol. 2023 Oct 13;23(1):369. doi: 10.1186/s12883-023-03422-0. BMC Neurol. 2023. PMID: 37833629 Free PMC article.
-
Antiplatelet Treatment Patterns and Outcomes for Secondary Stroke Prevention in the United Kingdom.Cardiol Ther. 2023 Dec;12(4):675-687. doi: 10.1007/s40119-023-00332-7. Epub 2023 Oct 4. Cardiol Ther. 2023. PMID: 37789237 Free PMC article.
-
Food Insecurity and Perceived Financial Stress are Associated with Cost-related Medication Non-adherence in Stroke.J Health Care Poor Underserved. 2023;34(2):625-639. doi: 10.1353/hpu.2023.0054. J Health Care Poor Underserved. 2023. PMID: 37464522 Free PMC article.
References
-
- Roger V, Go A, Lloyd-Jones D, et al. Heart disease and stroke statistics 2011 update: a report from the American Heart Association. In: Circulation [serial online] 2010. Available at: http://circ.ahajournals.org Accessed December 23, 2010 - PMC - PubMed
-
- Sacco R, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke. Stroke 2006;37:577–617 - PubMed
-
- Glader E-V, Sjolander M, Eriksson M, Lundberg M. Persistent use of secondary preventive drugs declines rapidly during the first 2 years after stroke. Stroke 2010;41:2552–2558 - PubMed
-
- Shaya F, El Khoury A, Mullins C, et al. Drug therapy persistence and stroke recurrence. Am J Manag Care 2006;12:313–319 - PubMed
-
- Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487–497 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical